|
|
PPTA Letter to Stakeholders re: North America Data Program (February 3, 2012)
February 3, 2012
PPTA is pleased to announce that reporting of data on the U.S. supply of certain plasma protein therapies has resumed.
|
|
more >>
|
| |
|
|
PPTA Letter to Stakeholders re: North America Data Program (Nov 15, 2011)
November 15, 2011
PPTA is implementing modifications to the data program, the most notable of which is the move from a one-month reporting lag to a three-month reporting lag. Product supply data reported by participating manufacturers in October 2011 will be reported on PPTA’s Web site in early February 2012. This change is effective immediately. PPTA’s commitment to shortage preparedness-related supply data reporting remains firm. We believe these changes will make the North America data program even stronger and more useful to stakeholders.
|
|
more >>
|
| |
|
|
California State Assemblymember Atkins Honored At PPTA's Business Forum
October 27, 2011
ANNAPOLIS, MD (October 27, 2011) The Plasma Protein Therapeutics Association (PPTA) honored California State Assemblymember Toni Atkins (D) of San Diego as State Legislator of the Year for 2011-2012. Assemblymember Atkins received the award at the 2011 PPTA Source Business Forum taking place earlier this week in San Diego, California.
|
|
more >>
|
| |
|
|
PPTA Attends FDA Public Workshop on Drug Shortages
September 27, 2011
ANNAPOLIS, MD (September 27, 2011) The Plasma Protein Therapeutics Association (PPTA) attended a U.S. Food and Drug Administration (FDA)–sponsored workshop to address growing concerns regarding drug shortages in certain sectors of the pharmaceutical industry September 26. The workshop convened a diverse group of stakeholders including manufacturers, wholesalers, patients, physicians, regulators and policymakers to address the causes of drug shortages and potential responses. FDA staff expressed an interest in timely, bi-directional communications with stakeholders.
|
|
more >>
|
| |
|
|
Californians And Floridians Recognized For Role In Helping Rare Disease Patients Who Need Lifesaving Therapies
September 1, 2011
(September 1, 2011) – This month, Florida and California are recognizing “Plasma Protein Therapies Month,” by raising awareness for the valuable contributions of plasma donors and for the rare, genetic diseases treated with the therapies that are made possible through plasma donation.
|
|
more >>
|
| |
|
|
ConQuaestor Report Confirms Cross Subsidies Within Sanquin
August 29, 2011
(August 29, 2011) The Plasma Protein Therapeutics Association (PPTA) welcomes the findings of the ConQuaestor report on the financing of Sanquin, the Dutch National Fractionator.
|
|
more >>
|
| |
|
|
IRS Proposed Regulations on Orphan Drug Exclusion from Drug Tax Stand to Harm Future Development of Treatments for Rare Disease Patients
August 19, 2011
(August 19, 2011) The Plasma Protein Therapeutics Association (PPTA) believes the Internal Revenue Services’ issuance of temporary and proposed regulations implementing the annual pharmaceutical fee undermines patients with rare diseases and fails to take into account concerns expressed by leading consumer organizations and Congress.
|
|
more >>
|
| |
|
|
PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies
August 18, 2011
(August 18, 2011)—The Plasma Protein Therapeutics Association (PPTA) recommends that the Centers for Medicare and Medicaid Services (CMS) take necessary steps to improve drug reimbursement under the Hospital Outpatient Perspective Payment System (OPPS).
|
|
more >>
|
| |
|
|
PPTA Praises Legislation that Protects the Treatment of Rare Diseases
July 29, 2011
(July 29, 2011) The Plasma Protein Therapeutics Association (PPTA) applauds the introduction of bipartisan legislation, the Preserving Access to Orphan Drugs Act (H.R. 2672) and (S. 1423), which will safeguard the development of drugs and therapies that treat patients with rare diseases by eliminating barriers to innovation.
|
|
more >>
|
| |
|
|
PPTA Opposes Tax on Blood Clotting Factor
June 15, 2011
(June 15, 2011) PPTA opposes New Jersey Assembly Bill 2003 passed by the New Jersey Assembly Appropriations Committee on June 13 that imposes a new tax on therapies used to treat bleeding disorders like hemophilia.
|
|
more >>
|
| |
|
|
PPTA Industry Expert Invited To Serve On HHS Advisory Committee On Blood Safety And Availability
June 10, 2011
(June 10, 2011) The U.S. Department of Health and Human Services (HHS) has appointed Plasma Protein Therapeutics Association (PPTA) industry expert Mary Gustafson to serve for a two-year term on its Advisory Committee on Blood Safety and Availability (ACBSA).
|
|
more >>
|
| |
|
|
PPTA Hosts Discussion Forum on Blood/Plasma Products in The Hague
May 25, 2011
(May 25, 2011) The Plasma Protein Therapeutics Association (PPTA) hosted a discussion forum at the Dutch Parliament in The Hague yesterday. The forum was attended by representatives of the Dutch Ministry of Health, Members of the Dutch Parliament, the patient community and the national manufacturer of plasma protein therapies: Sanquin.
|
|
more >>
|
| |
|
|
PPTA Applauds the Florida Legislature for Preserving Medicaid Patient Access to Blood Clotting Factor
May 17, 2011
(May 17, 2011) The Plasma Protein Therapeutics Association commends the Florida legislature for allowing Medicaid recipients to continue to receive their clotting factor and the overlay services through the agency's hemophilia disease management program, rather than forcing them to switch to a managed care plan for their therapeutic needs.
|
|
more >>
|
| |
|
|
PPTA Commends Congress and President Obama for Repealing the 1099 Tax-reporting Provision
April 15, 2011
(April 15, 2011) The Plasma Protein Therapeutics Association (PPTA) applauds Congress and President Obama for preserving patient access to safe and effective plasma protein therapies by repealing the 1099 tax-reporting provision.
|
|
more >>
|
| |
|
|
New Spanish Language Translations Available on PPTA Websites
April 14, 2011
(April 14, 2011) – The Plasma Protein Therapeutics Association (PPTA) recently updated the Association’s global website and its website on plasma donation with Spanish language translations of some materials posted online to better serve consumers.
|
|
more >>
|
| |
|
|
PPTA Hosts Congressional Staff Briefing
April 4, 2011
(April 4, 2011) PPTA collaborated with the patient community to host a Congressional staff briefing focused on the uniqueness of plasma protein therapies and the importance of access.
|
|
more >>
|
| |
|
|
PPTA Statement: Proven Safety of Human Albumin
March 7, 2011
(March 7, 2011) Statements in the international media have described the events resulting from the retraction by several leading medical journals of a large number of articles describing scientific studies by a German physician, Joachim Boldt. Boldt was dismissed from his position as head of anesthesia in the Klinikum Ludwigshafen in the state of Rheinland-Pfalz in Germany in November 2010, following initial findings by a leading anesthesia journal that a paper describing a clinical study which Boldt published in the journal had been fabricated.
|
|
more >>
|
| |
|
|
New German Language Video On Plasma Donation Available
March 2, 2011
(March 2, 2011) – Anyone curious about what to expect as a plasma donor and how plasma contributes to lifesaving medicines can now learn about the process thanks to a new German language DVD from the Plasma Protein Therapeutics Association (PPTA).
|
|
more >>
|
| |
|
|
PPTA Recognizes Rare Disease Day
February 28, 2011
(Feburary 28, 2011) Today, the Plasma Protein Therapeutics Association (PPTA) is proud to support the National Organization for Rare Disorders (NORD) in raising awareness for the needs of individuals coping with rare diseases by joining the organization in recognizing Rare Disease Day.
|
|
more >>
|
| |
|
|
PPTA Invited By MHLW To Give Presentation in Japan
February 9, 2011
(February 9, 2011) - The Plasma Protein Therapeutics Association (PPTA) was invited by the Japanese Ministry of Health, Labor and Welfare (MHLW) to present its opinion to a panel that is looking into the future supply of plasma protein therapies into Japan.
|
|
more >>
|
| |
|
|
PPTA Statement Regarding Octagam
September 27, 2010
PPTA has learned that in many countries there has been a product recall/product withdrawal as well as suspension of the license of Octagam 5% and Octagam 10%. This product is manufactured by Octapharma.
|
|
more >>
|
| |
|
|
Jack Ryan Remembered
September 7, 2010
We received the sad news that Jack Ryan, a dear friend and industry leader, passed away from cancer.
|
|
more >>
|
| |
|
|
Californians And Minnesotans Help Produce As Well As Benefit From Lifesaving Therapies
September 1, 2010
ANNAPOLIS, MD (September 1, 2010) – This month, Californians and Minnesotans are recognized for their outstanding contributions to lifesaving therapies that treat critically ill individuals and for their donations of the blood component, plasma, that make the creation of these unique therapies possible. California and Minnesota are recognizing September 2010 as “Plasma Protein Therapies Month,” helping to raise awareness for the rare, genetic diseases treated with the therapies and to value the contributions of voluntary plasma donors in the states.
|
|
more >>
|